By Anthony Caruso III | Publisher
Jon Jones has a fight with Anthony Smith this Saturday night at UFC 235. Yet, due of his drug tests leading up to the fight, have been founded to have traces of M3 metabolite.
This is an oral turinabol. Jones has been busted for failing drug tests before MMA Junkie’s John Morgan broke the latest developments.
Morgan insists that the Nevada State Athletic Commission (NSAC) detected that Jones had 40 pg/mL or less of M3 metabolite in his system.
“No scientific or medical evidence that the athlete would have an unfair advantage leading up to, or for, his contest scheduled on March 2, 2019,” the NSAC said in a statement.
The 31-year-old Rochester, New York native will put his UFC Light Heavyweight Championship on the line against Smith. He won his last fight against Alexander Gustafsson in a third-round TKO (Punches) in Inglewood, California.
It is believed that Jones could have this in his system for more than a year. The Nevada Athletic Commission (NAC) believe that this is the same metabolite that was in his system before his UFC 214 fight in July 2017.
He was then hit with a 15 month suspension from USADA for the violation in question.
In Dec., though, when he was tested, there was reportedly no presence of M3 metabolite in his system when he was tested several times before the fight with Gustafsson.
According to MMAFighting.com, it was found in Jones’ Feb. 14 and Feb. 15 tests by NAC. However, he was clean on Feb. 18 by VADA for NAC. He also has a Feb. 23 test pending.
Jones had his Feb. 1 and Feb. 9 tests come back clean.
In Dec., the UFC had to relocate Jones and Gustafsson from Las Vegas to Los Angeles because Jones’ tests from Aug. through Dec. were positive for the drug. Nevada, at the time, were not comfortable with Jones fighting so the event was moved.
Any Corrections?. You can contact Anthony Caruso III, Publisher at email@example.com.
©2007-2019 The Capital Sports Report. Please honor copyright! Piracy hurts writers, devalues their works, and puts you and your employer at risk of lawsuits. All original materials contained on this website are protected by the United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcasted without the prior written permission.